Development of UHPLC-MS/MS methods to quantify 25 antihypertensive drugs in serum in a cohort of patients treated for hypertension.

MLA

Thorstensen, Christian W., et al. “Development of UHPLC-MS/MS Methods to Quantify 25 Antihypertensive Drugs in Serum in a Cohort of Patients Treated for Hypertension.” Journal of Pharmaceutical & Biomedical Analysis, vol. 219, Sept. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jpba.2022.114908.

APA

Thorstensen, C. W., Clasen, P.-E., Rognstad, S., Haldsrud, R., Føreid, S., Helstrøm, T., Bergland, O. U., Halvorsen, L. V., Aune, A., Olsen, E., Brobak, K. M., Høieggen, A., Gustavsen, I., Larstorp, A. C. K., Søraas, C. L., & Opdal, M. S. (2022). Development of UHPLC-MS/MS methods to quantify 25 antihypertensive drugs in serum in a cohort of patients treated for hypertension. Journal of Pharmaceutical & Biomedical Analysis, 219, N.PAG. https://doi.org/10.1016/j.jpba.2022.114908

Chicago

Thorstensen, Christian W., Per-Erik Clasen, Stine Rognstad, Renate Haldsrud, Siri Føreid, Trine Helstrøm, Ola Undrum Bergland, et al. 2022. “Development of UHPLC-MS/MS Methods to Quantify 25 Antihypertensive Drugs in Serum in a Cohort of Patients Treated for Hypertension.” Journal of Pharmaceutical & Biomedical Analysis 219 (September): N.PAG. doi:10.1016/j.jpba.2022.114908.